Technology Review, of course, is all about the future, and the companies and people involved in the innovation that will get us there. It is in that spirit that we introduce the Technology Review Index, which includes the TR Large-Cap 100 and its sibling, the TR Small-Cap 50. Developed in conjunction with Standard and Poor’s, these global equity indices will serve as our own in-house gauge of the pulse of innovation at 150 of the world’s most important public companies.
Our two indices will track both the most powerful innovators and the up-and-comers in the 10 most innovative industries of the global economy.
Each month, the editors of the magazine will discuss the performance of the Technology Review indices, their constituent industries, and any of their component stocks that stand out in particular. This review should, we think, provide an invaluable reference point for those with a stake in innovation – both today and in the future.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Crypto is weathering a bitter storm. Some still hold on for dear life.
When a cryptocurrency’s value is theoretical, what happens if people quit believing?
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.